Canadian trial prompts Bayer to halt marketing of anti-bleeding drug

FRANKFURT, Germany - Pharmaceutical company Bayer AG suspended global marketing of its anti-bleeding drug Trasylol on Monday after a Canadian clinical trial found that it could be linked to a higher risk of death than other such drugs....More